Emerging Role of Angiotensin AT2 Receptor in Anti-Inflammation: An Update

Curr Pharm Des. 2020;26(4):492-500. doi: 10.2174/1381612826666200115092015.

Abstract

The hyperactive RAS and inflammation are closely associated. The angiotensin-II/AT1R axis of the RAS has been explored extensively for its role in inflammation and a plethora of pathological conditions. Understanding the role of AT2R in inflammation is an emerging area of research. The AT2R is expressed on a variety of immune and non-immune cells, which upon activation triggers the release of a host of cytokines and has multiple effects that coalesce to anti-inflammation and prevents maladaptive repair. The anti-inflammatory outcomes of AT2R activation are linked to its well-established signaling pathways involving formation of nitric oxide and activation of phosphatases. Collectively, these effects promote cell survival and tissue function. The consideration of AT2R as a therapeutic target requires further investigations.

Keywords: Angiotensin-II type 2 receptor; immune and non-immune cells; inflammation; maladaptive repair; nitric oxide; pathological conditions..

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Humans
  • Inflammation / immunology*
  • Inflammation / pathology
  • Nitric Oxide / metabolism
  • Phosphoric Monoester Hydrolases / metabolism
  • Receptor, Angiotensin, Type 2 / metabolism*
  • Renin-Angiotensin System
  • Signal Transduction*

Substances

  • Receptor, Angiotensin, Type 2
  • Nitric Oxide
  • Phosphoric Monoester Hydrolases